Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126435171 | 12643517 | 1 | I | 20160728 | 20160811 | 20160811 | EXP | US-AUROBINDO-AUR-APL-2016-10288 | AUROBINDO | 0.00 | Y | 0.00000 | 20160811 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126435171 | 12643517 | 1 | PS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | U | 206781 | ||||||||||
126435171 | 12643517 | 2 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | UNK | U | 0 | |||||||||
126435171 | 12643517 | 3 | SS | DOXORUBICIN | DOXORUBICIN | 1 | Unknown | U | 0 | ||||||||||
126435171 | 12643517 | 4 | SS | VINCRISTINE | VINCRISTINE | 1 | Unknown | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126435171 | 12643517 | 1 | Acute lymphocytic leukaemia |
126435171 | 12643517 | 2 | Acute lymphocytic leukaemia |
126435171 | 12643517 | 3 | Acute lymphocytic leukaemia |
126435171 | 12643517 | 4 | Acute lymphocytic leukaemia |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126435171 | 12643517 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126435171 | 12643517 | Sepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |